Evercore ISI raised the firm’s price target on Teladoc (TDOC) to $9 from $8 and keeps an In Line rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc Stock Surges Amid Bullish Options Activity
- Unusually active option classes on open October 3rd
- Teladoc put volume heavy and directionally bearish
- Teladoc call volume above normal and directionally bullish
- Teladoc’s Transition to Insurance-Based Model and Mixed Growth Signals Lead to Hold Rating